Skyward Specialty announces expansion of Life Sciences insurance solution

Skyward announced the global expansion of Skyward Specialty’s Life Sciences insurance solution. Through this expansion, and by leveraging Apollo’s Lloyd’s Syndicate 1969, Skyward Specialty now offers enhanced multinational placements for U.S.-domiciled life sciences companies with international operations. This initiative marks the first strategic collaboration between Skyward Specialty and Apollo since the acquisition closed earlier this month. Skyward Group Chairman and Chief Executive Officer Andrew Robinson said, “The expansion of our Life Sciences product reflects the strength of our combined organization and our ability to unlock new opportunities together. We quickly recognized the complementary capabilities across both organizations and saw this expansion as a natural first step in working together. Apollo’s Lloyd’s platform and global licensing provides efficient access to support specialty risks on a global scale and when paired with Skyward Specialty’s underwriting expertise, we can scale a high-quality portfolio while mainitaining the discipline and technical focus that drive our sustainable, durable competitive advantage.”